Replies to post #160273 on Biotech Values

[north40000]

Some info re Intarcia here:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=64802289&txt2find=intarcia|amylin

You might search InvestorVillage board for Amylin for further discussion.

I think Kurt Graves, ex Vertex, is involved with Intarcia.

There is also some controversy whether Amylin's original, still extant patent relating to exenatide would dominate this device of Intarcia.

[DewDiligence]

Tysabri sales increased 28% from Q1 2012.

How much of that was volume and how much was pricing?